to restore the cellular redox status. In endothelial and smooth muscle cells of young animals in which the system is functional, Nrf2 is released from Keap1 in response to oxidative stress and translocates to the nucleus, where it activates ARE-dependent transcription of phase II and antioxidant defense enzymes, including NAD(P)H:quinone oxidoreductase 1 (NQO1, a key component of the plasma membrane redox system) and g-glutamylcysteine ligase (GCLC, the rate-limiting enzyme for GSH synthesis), heme oxygenase-1 (HMOX-1), catalase, glutathione peroxidase, and that of peroxiredoxins, all of which participate in attenuating cellular oxidative stress. Previous studies demonstrated that although there is a significant age-dependent increase in cellular ROS production in aged animals (6, 7) , an adaptive Nrf2/ARE-driven antioxidant response fails to manifest in the aged vasculature (8, 9) . Recent studies by our laboratories (9) and others (10) demonstrate that aging in blood vessels of laboratory rodents and nonhuman primates is associated with Nrf2 dysfunction, which likely exacerbates age-related cellular oxidative stress and ROSinduced cellular injury in aging. Moreover, age-accelerated atherosclerosis correlates with failure to upregulate Nrf2-driven antioxidant genes (10) . Despite their high relevance to cardiovascular pathophysiology in the elderly human, the mechanisms responsible for Nrf2 dysfunction in aging are currently unknown.
In recent years, an increasing body of evidence became available, suggesting that in addition to cell autonomous changes in the gene expression signature, noncell autonomous endocrine mechanisms also have an important role in age-related cardiovascular alterations. In particular, whether reduced insulin-like growth factor (IGF)-1 levels are directly associated with an age-related decline in cardiovascular physiological function remains a seminal question (11, 12, 13) . In aging, hepatic production of IGF-1 significantly declines both in humans and in laboratory animals (14, 15, 16) . There is ample clinical and experimental evidence that IGF-1 exerts positive effects on cardiovascular function and cardiovascular mortality (12, 17, 18, 19, 20, 21, 22, 23, 24, 25) and is atheroprotective (26, 27) . Importantly, our recent studies in IGF-1-deficient Ames dwarf mice (28) and Lewis dwarf rats (29) demonstrate that low circulating IGF-1 levels are associated with impaired expression/activity of antioxidant enzymes in the vasculature, leading to increased vascular oxidative stress and endothelial dysfunction (28) . Yet, the association between IGF-1 deficiency, Nrf2 dysfunction, and impaired vascular oxidative stress resistance is not well understood.
We postulate that if circulating IGF-1 is a key regulator of vascular oxidative stress resistance, then isolated endocrine IGF-1 deficiency should mimic the aging phenotype, impairing Nrf2 activity and rendering the vasculature sensitive to oxidative stressors. However, until now, this hypothesis was difficult to test as currently used animal models of IGF-1 deficiency have several disadvantages. First, the available models often exhibit other complex endocrine defects (ie, chronic growth hormone [GH] , thyroid-stimulating hormone, and/or prolactin deficiency). Second, IGF-1 deficiency generally is present during development in these animal models, which results in dwarfism and/or altered metabolism. Third, there is increasing evidence that circulating (liverderived, endocrine) and locally derived (paracrine) IGF-1 has unique physiological roles (26, 27, 30, 31, 32, 33, 34, 35, 36, 37) . Importantly, alterations in the paracrine IGF-1 system in animals with complex endocrine defects and/or with developmental IGF-1 deficiency are not well understood. Because aging is primarily characterized by a decline in circulating IGF-1, animal models of isolated endocrine IGF-1 deficiency should be used to mimic the aging phenotype.
The present study was designed to elucidate the effects of low circulating IGF-1 levels on vascular function and phenotype using a novel mouse model of adult-onset isolated endocrine IGF-1 deficiency induced by adeno-associated viral knockdown of IGF-1 specifically in the liver of postpubertal mice using Cre-lox technology. Using this model, we tested the hypothesis that adult-onset endocrine IGF-1 deficiency decreases vascular expression of Nrf2 and Nrf2 target genes and impairs vascular resistance to oxidative stress challenges, mimicking the aging phenotype.
Methods

Postdevelopmental Liver-Specific Knockdown of Igf1 in Mice
Adeno-associated viral knockdown of Igf1 specifically in the liver of postpubertal mice was achieved using Cre-lox technology. In brief, male mice homozygous for a floxed exon 4 of the Igf1 gene (Igf1 f/f ) were developed in a mixed 129Sv and C57BL/6 background (38) . Briefly, these mice have the entirety of exon 4 of the Igf1 gene flanked by loxP sites, which allows for genomic excision of this exon when exposed to Cre recombinase. Transcripts of the altered Igf1 gene yield a protein upon translation that fails to bind the IGF receptor. The line was generated in embryonic stem cells from 129Sv mice, correctly targeted clones were injected into C57BL/6 blastocysts, and chimeric males were bred to C57BL/6 females. The line at the University of Oklahoma Health Sciences Center (OUHSC) was rederived at Charles River Laboratories in a C57BL/6 background for maintenance of the colony in a specific pathogen-free rodent barrier facility. Animals were bred to homozygosity and housed in the Rodent Barrier Facility at OUHSC on a 12-hour light/12-hour dark cycle and given access to standard rodent chow (Purina Mills, Richmond, IN) and water ad libitum. All procedures were approved by the Institutional Animal Care and Use Committee of OUHSC.
To specifically target hepatocytes, pseudotyped AAV2/8 viruses were packaged with a major urinary protein (MUP)-iCRE transgene cassette consisting of the MUP promoter and iCre, a codon-optimized Cre recombinase gene (39) . Although AAV8 is effective at transducing multiple tissues after intravenous delivery, including liver, the MUP promoter restricts expression solely to hepatocytes. Control viruses encoding enhanced green fluorescent protein (eGFP) were also generated (MUP-eGFP-AAV8). Viruses were packaged according to a triple transfection protocol described previously (39) . Briefly, the viruses were produced using AAV2 plasmids containing AAV2 inverted terminal repeats flanking a transgene cassette consisting of the MUP promoter, the gene of interest (iCre or eGFP), and an intron polyadenylation sequence derived from SV40. Triple transfection of AAV-293 cells with these plasmids, an AAV2/8 rep/cap plasmid (producing AAV2 replicase and AAV8 capsid), and pHelper plasmid (Stratagene, La Jolla, CA) were used to package the virus. Cells were harvested 72 hours after transfection, and clarified viral lysates were obtained. Lysates were titred by real-time polymerase chain reaction (PCR) and stored at −80°C. At 4 months of age, mice were anesthetized with ketamine and xylazine (100 mg/kg/15 mg/kg, respectively) and given retro-orbital injections of 1.5 × 10 10 particles of either MUP-iCre-AAV8 or MUP-eGFP-AAV8 diluted in saline for a total injection volume of 100 mL per animal. Dosages were determined empirically in preliminary studies. Hepatocyte specificity of intravenously administered MUP-AAV8 vectors has been previously demonstrated (39) .
Measurement of Circulating IGF-1 Levels
Submandibular venous blood was collected into microcentrifuge tubes using a sterile lancet (Medipoint, Mineola, NY) according to the manufacturer's instructions. Whole blood was centrifuged at 2500g for 20 minutes at 4°C to collect serum, which was then stored at −80°C. Serum was processed for enzyme-linked immunosorbent assay of IGF-1 (R&D Systems, Minneapolis, MN) according to the manufacturer's protocol. Serum IGF-1 levels are reported in nanograms per milliliter. An IGF-1 control sample, with aliquots stored at −80°C, was included on each plate.
Vessel Isolation and Functional Studies
Mice with liver-specific knockout of Igf1 and the respective controls (termed "Igf1 f/f + MUP-iCre-AAV8" and "control," respectively) were sacrificed (after overnight fasting, between 8 and 10 am) by decapitation 7 months after the viral transfection. The aortas were isolated, and endothelial function was assessed by measuring relaxation of aortic ring preparations in response to acetylcholine as previously described (40) . In brief, an aorta ring segment 2 mm in length was isolated from each animal and mounted on 40 mm stainless steel wires in myograph chambers (Danish Myo Technology A/S, Inc., Denmark) for measurement of isometric tension. The vessels were superfused with Krebs buffer solution (118 mM NaCl, 4.7 mM KCl, 1.5 mM CaCl 2 , 25 mM NaHCO 3 , 1.1 mM MgSO 4 , 1.2 mM KH 2 PO 4 , and 5.6 mM glucose; at 37°C; gassed with 95% air and 5% CO 2 ). After an equilibration period of 1 hour during which an optimal passive tension was applied to the rings (as determined from the vascular length-tension relationship), relaxation of precontracted (by 10 −6 mol/L phenylephrine) vessels to acetylcholine (ACh; from 10 −9 to 10 −6 mol/L) was obtained.
Measurement of Vascular ROS Production
H 2 O 2 production in aorta segments was measured fluorometrically using the Amplex Red/horseradish peroxidase assay as described (41 
Determination of Endogenous Glutathione and Ascorbate Using High-Performance Liquid Chromatography Electrochemical Detection
Concentrations of redox-active GSH and ascorbate were measured in aorta homogenates using a Perkin-Elmer highperformance liquid chromatography equipped with an eight-channel amperometric array detector as described (29, 42) . In brief, 10 mg aliquots of tissue samples were washed with ice-cold phosphate-buffered saline and homogenized in 5% (w/v) metaphosphoric acid. Samples were centrifuged at 10,000g for 10 minutes to sediment protein, and the supernatant fraction was stored for analysis of redoxsensitive compounds. Precipitated proteins were dissolved in 0.1 N NaOH and stored for protein determination by a spectrophotometric quantitation method using BCA reagent (Pierce Chemical Co., Rockford, IL). Concentrations of GSH and ascorbic acid in supernatant fractions were determined by injecting 5 mL aliquots onto an Ultrasphere 5 u, 4.6 × 250 mm C18 column and eluting with mobile phase of 50 mM NaH 2 PO 4 , 0.05 mM octane sulfonic acid, and 1.5% acetonitrile (pH 2.62) at a flow rate of 1 mL/min. The detectors were set at 200, 350, 400, 450, 500, 550, 600, and 700 mV, respectively. Peak areas were analyzed using ESA, Inc. software, and concentrations of GSH and ascorbate are reported as nanomoles per milligram of protein.
Quantitative Real-Time Reverse Transcription-PCR
A quantitative real-time reverse transcription (RT)-PCR technique was used to analyze messenger RNA (mRNA) expression of Gpx1, Cat, Nrf2 and the Nrf2/ARE target genes Nqo1, Hmox1, and Gclc, as well as components of the paracrine IGF-1 system (Igf1, Igf1r, Igfbp1, Igfbp3, Igfbp4, Igfbp5) in the aorta as previously reported (6, 7, 43, 44) . In brief, total RNA was isolated with a Mini RNA Isolation Kit (Zymo Research, Orange, CA) and was reverse transcribed using Superscript III RT (Invitrogen, Carlsbad, CA) as described previously (7, 45) . A real-time RT-PCR technique was used to analyze mRNA expression using a Strategen MX3000 as reported (45) . Amplification efficiencies were determined using a dilution series of a standard vascular sample. Quantification was performed using the efficiencycorrected DDCq method. The relative quantities of the reference genes Ywhaz, B2m, Hprt, and Actb were determined, and a normalization factor was calculated based on the geometric mean for internal normalization. Oligonucleotides used for quantitative real-time RT-PCR are listed in Table 1 . Fidelity of the PCR reaction was determined by melting temperature analysis and visualization of the product on a 2% agarose gel.
Western Blotting
To analyze protein expression of Nrf2 and the Nrf2 targets NQO1 and GCLC, Western blotting was performed as described (41) using the following primary antibodies: rabbit anti-Nrf2 (Abcam, Cambridge, MA, ab31163, 1:1000 5% milk), rabbit anti-GCLC (Abcam, ab41463, 1 mg/mL in 5% milk), and rabbit anti-NQO1 (Abcam, ab34173, 1:2000 in 5% milk). All polyvinylidene difluoride membranes were incubated in primary antibodies overnight at 4°C. A donkey anti-rabbit secondary antibody was used (Abcam, ab16284; 1:2000 in 5% milk). Mouse anti-b-actin (Abcam, ab6276, 1:10,000 in 5% milk) and Coomassie staining were used for normalization purposes.
Organoid Culture
Aorta segments isolated from mice with hepatic IGF-1 deficiency and control mice were maintained in organoid culture (for 24 hours) as previously described (44) . Vessels were treated with H 2 O 2 (from 10 −6 to 10 −4 mol/L), high glucose (30 mmol/L, which effectively increases mitochondrial (46)), or oxidized low-density lipoprotein (LDL; 40 mg/mL, which elicits endothelial oxidative stress). At the end of the culture period, nuclear Nrf2-binding activity, mRNA expression of Nrf2 target genes, cellular antioxidant capacity, acetylcholine-induced vasorelaxation, and relative increases in apoptosis were assessed.
Nuclear Extraction and Nrf2-Binding Activity Assay
Nuclei were isolated from cultured aorta segments using the Nuclear Extraction kit from Active Motif (Carlsbad, CA). In brief, the vessels were homogenized with a dounce tissue homogenizer in 500 mL ice-cold hypotonic lysis buffer followed by two centrifugation steps (500g, for 30 seconds, 4°C) to exclude tissue debris. Then, nuclear proteins (~10 mg per vessel segment) were extracted according to the manufacturer's protocol. Protein concentrations in samples were equalized using a Bradford protein assay (Bio-Rad). Using the nuclear extract obtained, Nrf2-binding activity was assayed using the TransAM Nrf2 ELISA kit (Active Motif) according to the manufacturer's guidelines.
Cellular Antioxidant Capacity
To compare the capacity of cellular antioxidant systems to counterbalance the deleterious effects of oxidative stress in cultured aorta segments, we assessed the hydroxyl radical antioxidant capacity (HORAC) and oxygen radical absorbance capacity (ORAC) using the OxiSelect HORAC Activity Assay (Cell Biolabs) and the OxiSelect ORAC Activity Assay (Cell Biolabs Inc., San Diego, CA) as reported (47) . The HORAC Activity Assay is based on the oxidationmediated quenching of a fluorescent probe by hydroxyl radicals produced by a hydroxyl radical initiator and Fenton reagent. The ORAC Activity Assay is based on the oxidation of a fluorescent probe by peroxyl radicals produced by a free radical initiator. Antioxidants present in cells delay the quenching of the fluorescent probe until the antioxidant Assessment of
O in the wall of cultured aorta segments exposed to high glucose and oxLDL was determined using dihydroethidium (DHE), an oxidative fluorescent dye, as previously reported (29) . In brief, vessels were incubated with DHE (3 × 10 −6 mol/L; at 37°C for 30 minutes). The vessels were then washed three times, embedded in OCT medium and cryosectioned. Red fluorescent images were captured at 10× magnification and analyzed using the Metamorph imaging software as reported (28) . Three entire fields per vessel were analyzed with one image per field. The mean fluorescence intensities of DHE-stained nuclei in the endothelium and medial layer were calculated for each vessel. Thereafter, the intensity values for each animal in the group were averaged.
Apoptotic Cell Death
To compare cellular resistance with oxidative stress in cultured aorta segments of hepatic IGF-1-deficient mice and vessels of control mice, increases in the rate of apoptosis in response to treatment with high glucose or H 2 O 2 (10 −4 mol/L, for 24 hours) were assessed. The vessels were homogenized in lysis buffer, and cytoplasmic histone-associated DNA fragments, which indicate apoptotic cell death, were quantified by the Cell Death Detection ELISA Plus kit (Roche Diagnostics Corporation, Indianapolis, IN) as described (40, 48) . To visualize apoptotic cells in the vascular wall, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay was performed on frozen aorta sections as reported (48) . Propidium iodide was used for nuclear counterstaining. As an additional measure, caspase 3 activity, which is also a useful measure of apoptosis, was measured as reported (40) using the Caspase-Glo 3/7 assay system (Promega, Madison, WI). Luminescent intensity was measured using an Infinite M200 plate reader and were normalized to the sample protein concentration.
Assessment of the Effects of IGF-1 on the Transcriptional Activity of Nrf2 in Cultured Human Coronary Artery Endothelial Cells
In order to assess the direct effects of IGF-1 on endothelial Nrf2 signaling, human coronary artery endothelial cells (CAEC; Cell Applications, Inc., San Diego, CA; after Passage 4; age of the donors is unknown) were cultured in 96-well plates as described (28) . The control medium contained 5% heat-inactivated serum. The cells were treated with IGF-1.
The effect of recombinant IGF-1 (200 ng/mL, for 24 hours) on Nrf2 activity in CAECs was assessed using a reporter gene assay as described (4, 5, 9) . We used an ARE reporter comprised of tandem repeats of the ARE transcriptional response element upstream of firefly luciferase (SA Biosciences, Frederick, MD) and a renilla luciferase plasmid under the control of the CMV promoter (as an internal control). Transfections in CAECs were performed using the Amaxa Nucleofector technology (Amaxa, Gaithersburg, MD) as we have previously reported (4, 5, 9) . Firefly and renilla luciferase activities were assessed after 24 hours using the Dual Luciferase Reporter Assay Kit (Promega) and a Tecan Infinite M200 plate reader. The effect of recombinant IGF-1 (200 ng/mL, for 24 hours) on mRNA expression of Nqo1, Hmox1, and Gclc was assessed by quantitative real-time PCR.
In separate experiments, CAECs were triple transfected with a Nrf2-lucifierase reporter plasmid, a pRL Renilla Luciferase control vector (Promega), and one of the following plasmids expressing the wild-type human Akt1 or a dominant negative mutant form of Akt1 (Biomyx Human AKT1 ProteGene set; Biomyx, San Diego, CA): (a) pMEV2HA-AKT1-WT (A1010a; wild type), (b) pMEV2HA-AKT1-K179A (A1010b; K179A: AAG→GCG, no kinase activity), (c) pMEV2HA-AKT1-AA (A1010d; T308A: ACC→GCC; S473A: TCC→GCC, no kinase activity). Twenty hours after transfection, the cells were treated with or without IGF-1 (500ng/mL) for 4 hours. Firefly and renilla luciferase activities were assessed as described earlier.
Assessment of the Effects of IGF-1-Deficient Sera on oxLDL-Induced Changes in Nrf2 Activation, Expression of Nrf2 Target Genes, and
•− 2 O Production in Cultured Human Coronary Artery Endothelial Cells
CAECs were grown in 96-well plates in the presence of sera derived from Igf1 f/f + MUP-iCre-AAV8 and control mice. Then, the cells were treated with oxLDL (40 mg/mL, for 24 hours). The effects of oxLDL on Nrf2 activity and mRNA expression of Nqo1 and Hmox1 were assessed using a reporter gene assay and by quantitative real-time PCR, respectively (see above). oxLDL-induced changes in cellular
O production in cultured CAECs were assessed by flow cytometry using the redox-sensitive fluorescent dye dihydroethidium (DHE, 3x10 −6 mol/L, for 30 minutes) as previously reported (5, 42, 49) . The data are presented as relative oxLDLinduced changes in geometric mean intensity of DHE fluorescence, normalized to the respective mean fluorescence intensities obtained in cells grown in the absence of oxLDL in the presence of the same serum.
Data Analysis
Gene expression data were normalized to the respective control mean values. Statistical analyses of data were performed by one-way analysis of variance or by two-way analysis of variance followed by the Tukey post hoc test, as appropriate. p < .05 was considered statistically significant. Data are expressed as means ± SEM, unless otherwise indicated.
Results
Serum IGF1 Levels and Body Weight
IGF1 levels were measured in serum before and after the experimental period. Figure 1A shows that at the end of the experimental period, mice receiving MUP-iCre-AAV8 had significantly lower serum IGF1 levels compared with those receiving MUP-eGFP-AAV8. Both groups had similar serum IGF-1 levels prior to administration of liver-targeted viruses. The body mass of the control and experimental groups was similar throughout the experimental period (Table 2) .
Vascular Expression of Components of the Local IGF-1 System
We found that mRNA expression of Igf1, Igf1r, Igfbp1, Igfbp4, and Igfbp5 was unchanged in arteries of Igf1 f/f + MUP-iCre-AAV8 mice (data not shown). Expression of Igfbp3 tended to decrease in arteries of Igf1 f/f + MUP-iCre-AAV8 mice as compared with controls, yet the difference did not reach statistical significance (data not shown). 
Endothelial Function and Vascular Redox Status in Mice With Circulating IGF-1 Deficiency
Acetylcholine-induced vasorelaxation ( Figure 1B ) and vascular GSH content ( Figure 1D ) tended to be lower in the aortas of Igf1 f/f + MUP-iCre-AAV8 mice as compared with control Igf-1 f/f + MUP-eGFP-AAV8 mice, yet these differences did not reach statistical significance. IGF-1 deficiency did not affect significantly basal H 2 O 2 production ( Figure 1C ) or cellular ascorbate content ( Figure 1E ) in unstressed aortic segments of Igf1 f/f + MUP-iCre-AAV8 mice.
Effects of Circulating IGF-1 Deficiency on Expression of Nrf2 and Nrf2 Target Genes in Mouse Aortas
Expression of Nrf2 mRNA (Figure 2A ) was significantly decreased in aortas of Igf1 f/f + MUP-iCre-AAV8 mice as compared with controls. Protein expression of Nrf2 protein also tended to decrease in aortas of Igf1 f/f + MUP-iCre-AAV8 mice, yet the difference did not reach statistical significance. Although mRNA expression of the Nrf2 target genes Gclc ( Figure 3A) , Nqo1 ( Figure 3B ), and Hmox1 ( Figure 3C ) and catalase ( Figure 3D ) as well as protein levels of GCLC ( Figure 3E ) and NQO1 ( Figure 3F ) also tended to decrease in aortas of Igf-1 f/f + MUP-eGFP-AAV8 mice, these differences also did not reach statistical significance.
Effects of IGF-1 on Transcriptional Activity of Nrf2 in CAECs
To determine the effect of IGF-1 on Nrf2 activation, we transiently transfected CAECs with an Nrf2/ARE-driven reporter gene construct and then treated the cells with recombinant IGF-1. A significant increase in luciferase activity compared with the vector control was noted upon stimulation with IGF-1 ( Figure 4A ). IGF-1 also significantly increased mRNA expression of the known Nrf2 targets Nqo1, Hmox1, and Gclc ( Figure 4B and C) .
We also examined the role of the protein kinase Akt1 in the effect of IGF-1 in CAECs. Transfection of CAECS with a plasmid expressing a dominant negative form of Akt1 inhibited IGF-1-induced Nrf2 activation ( Figure 4D ).
Oxidative Stressors Elicit a Blunted Nrf2-Driven Antioxidant Response in Aortas of IGF-1-Deficient Mice
To determine whether reduced IGF-1 leads to Nrf2 dysfunction under cellular stress, we treated cultured aorta segments isolated from Igf-1 f/f + MUP-iCre-AAV8 and control Igf-1 f/f + MUP-eGFP-AAV8 mice with H 2 O 2 (10 −6 mol/L) and high glucose (30 mmol/L). In aortas of control mice, both H 2 O 2 and hyperglycemia elicited substantial upregulation of the Nrf2 target genes Gclc, Nqo1, Hmox1, and catalase, whereas these responses were significantly attenuated in aortas of IGF-1-deficient mice (Figure 5A-D) . In accordance with these results, we found that H 2 O 2 significantly increased Nrf2-binding activity in nuclear extracts from aortas of control mice, whereas H 2 O 2 -induced Nrf2 translocation to the nuclei was significantly less in aortas of IGF-1-deficient mice ( Figure 5E ).
Effects of Treatment With IGF-1-Deficient Serum on oxLDL-Induced Activation of the Nrf2-Driven Antioxidant Response in CAECs
To determine the acute effect of IGF-1 deficiency on the Nrf2-driven antioxidant response, we treated CAECs with sera derived from Igf1 f/f + MUP-iCre-AAV8 and control mice. Using a reporter gene assay, a significant decrease in oxLDL-induced Nrf2 activation was noted in CAECs treated with IGF-1-deficient sera ( Figure 6A ). In CAECs treated with IGF-1-deficient sera, as compared with cells treated with sera from control mice, oxLDL-induced upregulation of Nqo1 and Hmox1 expression ( Figure 6B and C, respectively) tended to be decreased, whereas oxLDL-induced ROS production tended to increase ( Figure 6D) ; however, these differences did not reach statistical significance. 
Circulating IGF-1 Deficiency Impairs the Ability of Vascular Cells to Increase Cellular Antioxidant Capacity in Response to Oxidative Stress Challenge
Endocrine IGF-1 deficiency did not affect significantly ORAC ( Figure 7A ) or HORAC ( Figure 7B ) in mouse aortas under baseline conditions. In mice with normal IGF-1 levels, there was a significant adaptive increase in HORAC in response to exposure to H 2 O 2 (10 −4 mol/L, for 24 hours), whereas this response was significantly impaired in vessels of the Igf1 f/f + MUP-iCre-AAV8 mice ( Figure 7A ). H 2 O 2 treatment also tended to increase ORAC selectively in mice with normal IGF-1 levels, but this response did not reach statistical significance ( Figure 7B ). Figure 8A depicts representative fluorescent images of cross-sections of DHE-stained aortas isolated from Igf1 f/f + MUP-iCre-AAV8 mice and control mice with or without exposure to oxidative stressors. Analysis of nuclear DHE fluorescent intensities indicated that IGF-1 deficiency did not significantly alter
Circulating IGF-1 Deficiency Exacerbates Vascular Oxidative Stress and Endothelial Dysfunction Elicited by High Glucose and oxLDL
O production in unstressed aortic segments ( Figure 8B ). In contrast, when exposed to oxLDL or high glucose, aortas from Igf1 f/f + MUP-iCre-AAV8 mice exhibited significantly more
O production than control vessels ( Figure 8B ). After treatment with high glucose or . Cells were transiently cotransfected with ARE-driven firefly luciferase and CMV-driven renilla luciferase constructs followed by IGF-1 treatment. Cells were then lysed and subjected to luciferase activity assay. After normalization relative luciferase activity was obtained from four to six independent transfections. Data are mean ± SEM. *p < .05. B-D: Effect of IGF-1 on messenger RNA expression of Nqo1, Hmox1, and Gclc in cultured primary CAECs. Data are mean ± SEM (n = 5 in each group). The effects of IGF-1 were significant (p < .05) for each target. E: Effect of IGF-1 on Nrf2/ARE reporter activity in CAECs transfected with plasmids expressing the wild-type human Akt1 (pMEV2HA-AKT1-WT) or a dominant negative mutant form of Akt1 (pMEV2HA-AKT1-K179A, pMEV2HA-AKT1-AA). Data are mean ± SEM (n = 6-8 in each group). *p < .05 versus untreated control, #p < .05 versus respective wild type.
oxidized LDL, acetylcholine-induced relaxation in aortas from Igf1 f/f + MUP-iCre-AAV8 mice was also significantly impaired compared with vessels from control mice ( Figure 8C and D, respectively).
Circulating IGF-1 Deficiency Exacerbates Oxidative Stress-Mediated Cellular Injury in Mouse Aortas
To further characterize hepatic IGF-1 deficiency-induced alterations in vascular oxidative stress resistance, we assessed sensitivity to apoptosis induced by oxLDL (40mg/mL, for 24 hours) and H 2 O 2 (10 −4 mol/L, for 24 hours). We found that in aortas from Igf1 f/f + MUP-iCre-AAV8 mice, both oxLDL and H 2 O 2 elicited significantly more apoptosis (as indicated by the greater increases in caspase 3/7 activity) than in control mice ( Figure 9A ). Analysis of oxLDL and H 2 O 2 -induced increases in cytoplasmic histone-associated DNA fragments, which also indicate apoptotic cell death, yielded similar results ( Figure 9B ). To localize apoptotic cells, we performed TUNEL assay. As shown in Figure 9C under unstressed conditions, the number of apoptotic cells in aortas control and Igf1 f/f + MUP-iCre-AAV8 mice were very low. In contrast, oxLDL significantly increased the number of TUNEL positive cells in each layer of the wall of aortas from Igf1 f/f + MUP-iCre-AAV8 mice. Analysis of the ratio of TUNEL positive nuclei in the aorta wall ( Figure 9D ) confirmed that hepatic IGF-1 deficiency sensitized vascular cells to oxLDL-induced cellular injury.
Discussion
In this study, we used adult-onset liver-specific knockout of Igf1 to elucidate the effects of isolated endocrine IGF-1 deficiency on vascular function and phenotype. This model is unique as early-life knockouts or null mutations of Igf1 can cause developmental abnormalities and/or lead to compensatory effects not seen in control animals. Moreover, recent studies (50,51) have provided strong evidence that in rodents, levels of IGF-1 during a critical developmental time window influence development of age-related diseases later in life. In contrast, our method generates normally developed animals with adult-onset isolated endocrine IGF-1 deficiency as we knockdown IGF-1 long after puberty. The degree of serum IGF-1 deficiency achieved in Igf1 f/f + MUP-iCre-AAV8 mice ( Figure 1A ) is translationally relevant as it closely mimics the aging phenotype in elderly humans (52) . It is known that a paracrine IGF-1 system is present in the vascular wall, which includes locally produced IGF-1, IGF-1R, and multiple binding proteins (53) . Because in our model expression of the aforementioned components of the local IGF-1 system was unaltered, we conclude that the vascular paracrine IGF-1 system cannot compensate for deficiency of circulating IGF-1. This conclusion is also supported by the lack of upregulation of local IGF-1 system in aortas of IGF-1-deficient Lewis dwarf rats (29) and in vessels of aged rodents despite the age-related decline in circulating IGF-1 (Csiszar, Sonntag, and Ungvari, unpublished observations, 2010).
Previous studies focused on the deleterious effects of low GH and IGF-1 on systemic cardiovascular risk factors but provided little information on vascular effects directly affected by endocrine IGF-1 deficiency. Here we demonstrate that although there is a trend for decreased endotheliumdependent vasorelaxation ( Figure 1B ) and lower GSH levels in the aorta of IGF-1-deficient mice, the degree of vascular impairment under unstressed conditions was less than what is usually found in aged animals. Previous studies have demonstrated that biological aging is characterized by significant oxidative stress in vascular cells and marked endothelial dysfunction under baseline conditions in laboratory rodents, nonhuman primates, and elderly human patients (1), suggesting that mechanisms other than endocrine IGF-1 deficiency (eg, cell-autonomous, age-related changes in mitochondrial phenotype) have a predominant role in agerelated increases in vascular ROS production.
In contrast, here we demonstrate for the first time that adult-onset endocrine IGF-1 deficiency in mice results in significant impairment of the Nrf2-driven antioxidant response pathway, which is a key regulator of vascular redox homeostasis under stressed conditions. In IGF-1-deficient mice, there was a trend for decreased expression of Nrf2 ( Figure 2 ) and Nrf2 target genes (Figure 3) , which mimics the vascular aging phenotype. Indeed, aging is associated with a downregulation of Nrf2 expression in blood vessels of both laboratory rodents and nonhuman primates (9, 54) . Recently, we also demonstrated downregulation of Nrf2 in O levels were assessed by flow cytometry using the redox-sensitive fluorescent dyes dihydroethidium. Data are mean ± SD. The difference between the groups is statistically not significant. the blood vessels of IGF-1-deficient Lewis dwarf rats (29) and decreased expression of Nrf2 target genes in the aorta of Ames dwarf mice (28) . It is significant that in the mouse hippocampus, IGF-1 deficiency also results in a ~40% decline in the mRNA expression of Nrf2 (in the present model, Sonntag et al., unpublished observation, 2011) and Nrf2 target genes (55) . Because Nrf2 expression and activity also decrease in the brain of aged mice (56) , further studies are warranted to compare the gene expression signatures induced by IGF-1 deficiency and aging in mice in multiple organs. Our results suggest that IGF-1, in addition to regulating Nrf2 signaling at the level of Nrf2 expression, can also directly modulate the transcriptional activity of Nrf2, likely by activating Akt1 (Figure 4) . Importantly, we found that low circulating IGF-1 levels impair the ability of vascular cells to mount an effective Nrf2-driven antioxidant defense upregulating ROS-detoxifying enzymes ( Figure 5 ) and increasing cellular antioxidant capacity ( Figure 7 ) in response to oxidative stress challenges. Our ex-vivo findings on cells treated with IGF-1-deficient sera give further support for this concept ( Figure 6 ). The Nrf2 dysfunction induced by endocrine IGF-1 deficiency directly mimics the vascular aging phenotype in that isolated arteries, and cultured endothelial and smooth muscle cells derived from aged animals also exhibit a dysfunctional Nrf2-driven response under oxidative stress conditions (9, 54) . Dysregulation of Nrf2 in IGF-1-deficient mice is associated with an impaired ability of vascular cells to withstand diverse oxidative stress challenges, showing the functional relevance of our findings. Specifically, endocrine IGF-1 deficiency exacerbates vascular oxidative stress ( Figure 8B ) and endothelial dysfunction ( Figure 8C and D, respectively) elicited by both hyperglycemia and the proatherogenic stressor oxLDL. Previously, we demonstrated that genetic lack of functional Nrf2/ARE pathway also results in significant increases in vascular ROS levels and exacerbation of endothelial dysfunction in arteries of type 2 diabetic Nrf2 −/− mice (5) . The finding that IGF-1 deficiency increases vascular sensitivity to multiple stressors, which elicit overproduction of ROS and cellular dysfunction by activating different pro-oxidant mechanisms, supports the concept that IGF-1 deficiency predominantly impairs the cellular oxidative defense pathway(s) that lie downstream from increased ROS production. Overall, our results are in line with the available clinical and experimental evidence, suggesting that IGF-1 deficiency renders the cardiovascular system more vulnerable to the deleterious effects of oxidative stress conditions. For example, even a 20% decline in circulating IGF-1 was reported to significantly increase atherosclerosis progression in ApoE knockout mice fed a Western diet (57) . In contrast, infusion of IGF-1 to ApoE-null mice significantly decreases high-fat diet-induced vascular oxidative stress, atherosclerotic plaque progression, and vascular inflammation (27) . Overexpression of IGF-1 in vascular smooth muscle cells was also reported to improve atherosclerotic plaque stability (32) , likely by preventing cellular oxidative damage.
Recent findings demonstrate that Nrf2-driven free radical detoxification pathways confer significant antiapoptotic effects in vascular endothelial and smooth muscle cells (58) . As expected, Nrf2 dysfunction in IGF-1-deficient mice was associated with exacerbation of the proapoptotic effects of oxidative stressors (Figure 9 ), further substantiating the concept that isolated adult-onset endocrine IGF-1 deficiency impairs vascular oxidative stress resistance. Recent studies investigating resistance to oxidative stress-induced cellular damage in nonvascular cells from rodent models of mixed GH/IGF-1 deficiency yielded controversial results. Even though the Ames dwarf mice show increased resistance to diquat-induced mortality, their livers sustain significantly greater diquat-induced damage than those of normal littermates (59) . Similarly, male GH receptor knockout mice are also more susceptible to paraquat toxicity as compared with controls (60) . The liver of Ames dwarf mice also appears to be more sensitive to acetaminophen-induced oxidative damage (61) . In culture, H 2 O 2 -treated primary hepatocytes from Ames dwarf mice show lower viability and a higher rate of apoptosis when compared with peroxidetreated wild-type cells (62) . In contrast, fibroblasts derived from Ames and Snell dwarf mice exhibit increased cellular resistance to oxidative stressors (63, 64) . Contrary to our expectation, we recently found that fibroblasts derived from Lewis dwarf rats exhibit stress response signatures that are markedly different from those in GH/IGF-1-deficient mouse models (49) . The available human evidence also strongly support an important role for circulating factors in regulation of cellular oxidative stress resistance. Recent studies by the Longo laboratory clearly show that treatment of cells with sera from IGF-1-deficient patients with GH receptor deficiency significantly increases cellular sensitivity to H 2 O 2 -induced apoptosis (65) . Interestingly, in cultured aortic segments from wild-type mice, in-vitro treatment with serum from IGF-1-deficient Ames dwarf mice also results in a marked downregulation of antioxidant genes (28) . Importantly, unlike model organisms with similar mutations, IGF-1-deficient human patients with GH receptor deficiency appear to live shorter lives and have an elevated cardiac disease mortality (65) . Thus, the aforementioned data are consistent with the hypothesis that the effects of endocrine IGF-1 deficiency are unique to specific cell types, species, the age at which the hormonal changes occur, and the concomitant presence of other endocrine deficiencies.
We propose that by comparing multiple organs in mouse models of adult-onset endocrine IGF-1 deficiency at different ages, many of the controversies that exist in the field could be resolved.
The mechanisms by which IGF-1 deficiency regulates Nrf2 activity are not fully understood. On ligand binding, the IGF-1 receptor tyrosine kinase initiates multiple signaling cascades, including activation of the phosphatidylinositol 3-kinase (PI3K) pathway and its downstream effectors (ie, Akt1). Our studies provide evidence that in endothelial cells, IGF-1 activates Nrf2 via an Akt1-dependent pathway ( Figure 4D ). Previous studies also demonstrated that IGF-1 receptor activation inhibits oxLDL-induced apoptosis in vascular smooth muscle cells through the PI3K/Akt signaling pathway (66) . Furthermore, antioxidative effects of IGF-1 in a mouse model of atherosclerosis are accompanied by an increased activation of Akt1 in the aorta (27) . Because recent evidence links PI3K phosphoryation to activation of Nrf2 (58, 67, 68) , our current working hypothesis is that IGF-1 deficiency impairs PI3K/Akt1-mediated Nrf2 activation, thereby promoting oxidative stress and ROS-mediated cellular injury in vascular endothelial and smooth muscle cells. Further studies are evidently needed to test this hypothesis and dissect the signaling pathways affected by hepatic IGF-1 deficiency in our mouse model. Nrf2 is thought to autoregulate its own expression through an ARE-like element located in the proximal region of its promoter (69); thus, it is possible that downregulation of Nrf2 in IGF-1-deficient mice is secondary to the impaired transcriptional activity of Nrf2.
In conclusion, our studies provide evidence that adultonset endocrine IGF-1 deficiency impairs the ability of vascular cells to mount an effective Nrf2-dependent antioxidant defense in response to increased levels of ROS, which likely renders the vasculature vulnerable to oxidative stress associated with aging and pathophysiological conditions associated with accelerated vascular aging (eg, metabolic diseases). Further studies are warranted to compare the effects of IGF-1 deficiency initiated at different ages (importantly, in the pre-and postpubertal period) and to dissect the signaling pathways underlying the regulation of Nrf2 pathway by IGF-1 in the vasculature.
